NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 194 filers reported holding NOVAVAX INC in Q2 2016. The put-call ratio across all filers is 2.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $10,000 | -56.5% | 7,200 | -37.1% | 0.00% | – |
Q3 2016 | $23,000 | -72.3% | 11,450 | +0.2% | 0.00% | – |
Q2 2016 | $83,000 | -65.6% | 11,431 | -75.5% | 0.00% | – |
Q1 2016 | $241,000 | -86.5% | 46,639 | -78.0% | 0.00% | -100.0% |
Q4 2015 | $1,781,000 | +17.4% | 212,386 | -0.9% | 0.00% | 0.0% |
Q3 2015 | $1,517,000 | -35.9% | 214,386 | +1.0% | 0.00% | -33.3% |
Q2 2015 | $2,366,000 | +35.1% | 212,336 | +0.3% | 0.00% | +50.0% |
Q1 2015 | $1,751,000 | +47.3% | 211,681 | +5.6% | 0.00% | +100.0% |
Q4 2014 | $1,189,000 | +42.2% | 200,500 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $836,000 | -9.7% | 200,500 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $926,000 | +17.5% | 200,500 | +15.2% | 0.00% | 0.0% |
Q1 2014 | $788,000 | -11.7% | 174,000 | -0.1% | 0.00% | 0.0% |
Q4 2013 | $892,000 | +62.8% | 174,200 | +0.1% | 0.00% | 0.0% |
Q3 2013 | $548,000 | – | 174,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |